Abstract

Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs

Author(s): Harrington Catherine A, Cauffield Jacintha

Issue: May/Jun 2005 - Veterinary Compounding

Page(s): 201-205

Download in electronic PDF format for $75
  • Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 1
  • Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 2
  • Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 3
  • Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 4
  • Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Page 5

Abstract

Selection of the “best” antihypertensive therapy was an issue of great debate among clinicians in the past. As large meta-analytic studies have shown, all antihypertensive drugs lower blood pressure by about the same amount; the main differences are in their side effects, cost, and frequency of administration. The side effect profiles, along with the patient’s comorbid conditions, should determine the combination of drugs to use. For the most part, side effects from antihypertensive drugs are predictable since they are dose related. When hypertension coexists with other cardiac conditions, drugs that treat both hypertension and other conditions at the same time should be chosen. Physicians should be encouraged to aggressively pursue treatment goals in hypertension, and meta-analysis has shown that combination drug therapy is the best way to reduce doses and side effects while maintaining effectiveness in blood pressure control. Compounded combinations let physicians tailor prescriptions to the patient; individualizing the mix of drugs and doses allows more aggressive treatment while controlling side effects and cost of therapy.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy
Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2003
Pg. 106-113
Author(s): Davidson Gigi S
May/Jun 2005
Pg. 201-205
Mar/Apr 2005
Pg. 117-119
Jan/Feb 2013
Pg. 74-85
View Sample
Sep/Oct 2009
Pg. 400-403
Author(s): Gilbert John A
Mar/Apr 2003
Pg. 129-134
View Sample
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 356
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 105-107
Author(s): Williams LaVonn A
Jul/Aug 2012
Pg. 294-298
Jul/Aug 2022
Pg. 298-301
Author(s): Ofei Kelvin
May/Jun 2016
Pg. 202-206
Author(s): Newton David W
Jul/Aug 2012
Pg. 350-351
Nov/Dec 2012
Pg. 456-460
Author(s): Lyon Joanna
Jul/Aug 2015
Pg. 295-300
Jan/Feb 2020
Pg. 30-36
Author(s): Dillon L R
Mar/Apr 2024
Pg. 111-116
May/Jun 2016
Pg. 217-222
Author(s): Akers Michael J
Mar/Apr 2018
Pg. 95-107
May/Jun 2004
Pg. 181-185
Nov/Dec 2011
Pg. 526-527
Author(s): Williams LaVonn A